Feng Wang

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial

Xiangrui Meng, Tao Wu, Yonggui Hong et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 82 citations

Second-line Treatment, Oncology, Esophageal Cancer +6

Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study

Huike Wang, Wei Qian, Yalan Yang et al. · Cancer Cell International · 2023 · 62 citations · Full text

Sirt1 improves heart failure through modulating the NF-κB p65/microRNA-155/BNDF signaling cascade

Bin Lin, Hui Zhao, Li Li et al. · Aging · 2020 · 57 citations · Full text

Res-trans networks for lung nodule classification

Dongxu Liu, Fenghui Liu, Yun Tie et al. · International Journal of Computer Assisted Radiology and Surgery · 2022 · 47 citations

Engineering, Medical Imaging, Deep Learning +8

<p>Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer</p>

Yao Lu, Dao Xin, Feng Wang · OncoTargets and Therapy · 2019 · 41 citations · Full text